Pesavento E, Capsoni S, Domenici L, Cattaneo A.

Acute cholinergic rescue of synaptic plasticity in the neurodegenerating cortex of anti-nerve- growth-factor mice.

Eur J Neurosci 2002;15(6):1030-1036

Pettegrew JW, Levine J, McClure RJ.

Acetyl-L-carnitine physical-chemical, metabolic and therapeutic properties: relevance for its mode of action in Alzheimer's disease and geriatric depression.

Mol Psychiatry 2000;5(6):616-632

Price JM, Chi X, Hellermann G, Sutton ET.

Physiological levels of beta-amyloid induce cerebral vessel dysfunction and reduce endothelial nitric oxide production.

Neurol Res 2001;23(5):506-512

Pringle AK, Niyadurupola N, Johns P, Anthony DC, Iannotti F.

Interleukin-1beta exacerbates hypoxia-induced neuronal damage, but attenuates toxicity produced by simulated ischaemia and excitotoxicity in rat organo- typic hippocampal slice cultures.

Neurosci Lett 2001;305(1):29-32

Qureshi AI, Suri MF, Ling GS, Khan J, Guterman LR, Hopkins LN.

Absence of et al.rly proinflammatory cytokine expression in experimental intracerebral hemorrhage. Neurosurgery 2001;49(2):416-20

Rafalowska U, Sulkowski G, Wasekiewicz J, Januszewski S, Kapuoscinski A.

Alteration of dopamine transport and dopamine D(2) receptor binding in the brain induced by late consequences of global ischaemia caused by cardiac arrest in the rat.

Resuscitation 2000;47(2):195-201

Rao AM, Hatcher JF, Dempsey RJ.

Neuroprotection by group I metabotropic glutamate receptor antagonists in forebrain ischemia of gerbil. Neurosci Lett 2000;293(1):1-4

Rattray M.

Is there nicotinic modulation of nerve growth factor? Implications for cholinergic therapies in Alzheimer's disease.

Biol Psychiatry 2001;49(3):185-193

Rebeck GW.

Confirmation of the genetic association of interleukin-1A with et al.rly onset sporadic Alzheimer's disease.

Neurosci Lett 2000;293(1):75-77

Reglodi D, Somogyvari-Vigh A, Vigh S, Maderdrut JL, Arimura A.

Neuroprotective effects of PACAP38 in a rat model of transient focal ischemia under various experimental conditions.

Ann N Y Acad Sci 2000;921:119-128

Reiriz J, Holm PC, Alberch J, Arenas E.

BMP-2 and cAMP elevation confer locus coeruleus neurons responsiveness to multiple neurotrophic factors. J Neurobiol 2002;50(4):291-304

Rosler N, Wichart I, Jellinger KA.

Clinical significance of neurobiochemical profiles in the lumbar cerebrospinal fluid of Alzheimer's disease patients.

J Neural Transm 2001;108(2):231-246

Royer C, Lachuer J, Crouzoulon G, Roux J, Peyronnet J, Mamet J et al..

Effects of gestational hypoxia on mRNA levels of Glut3 and Glut4 transporters, hypoxia inducible factor-1 and thyroid hormone receptors in developing rat brain.

Brain Res 2000;856(1-2):119-128

Ruscher K, Isaev N, Trendelenburg G, Weih M, Iurato L, Meisel A, Dirnagl U.Induction of hypoxia inducible factor 1 by oxygen glucose deprivation is attenuated by hypoxic preconditioning in rat cultured neurons.

Neurosci Lett 1998;254(2):117-120

Sasaki T, Hamada J, Shibata M, Araki N, Fukuuchi Y.

Inhibition of nitric oxide production during global ischemia ameliorates ischemic damage of pyramidal neurons in the hippocampus.

Keio J Med 2001;50(3):182-187

Savaskan E, Hock C, Olivieri G, Bruttel S, Rosenberg C, Hulette C, Muller-Spahn F.

Cortical alterations of angiotensin converting enzyme, angiotensin II and AT1receptor in Alzheimer's dementia.

Neurobiol Aging 2001;22(4):541-546

Savaskan E, Olivieri G, Meier F, Ravid R, Muller-Spahn F.

Hippocampal estrogen beta-receptor immunoreactivity is increased in Alzheimer's disease. Brain Res 2001;908(2):113-119

Schabitz WR, Hoffmann TT, Heiland S, Kollmar R, Bardutzky J, Sommer C, Schwab S.

Delayed neuroprotective effect of insulin-like growth factor-i after experimental transient focal cerebral ischemia monitored with mri.

Stroke 2001;32(5):1226-33

Schaub RT, Anders D, Golz G, Gohringer K, Hellweg R.

Serum nerve growth factor concentration and its role in the preclinical stage of dementia. Am J Psychiatry 2002;159(7):1227-1229

Scheinfeld MH, Roncarati R, Vito P, Lopez PA, Abdallah M, D'Adamio L.

Jun NH2-terminal kinase (JNK) interacting protein 1 (JIP1) binds the cytoplasmic domain of the Alzheimer's beta-amyloid precursor protein (APP).

J Biol Chem 2002;277(5):3767-3775

Schenk D, et al.

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in PDAPP mouse. Nature 1999:400;173-177

Schmidt-Kastner R, Truettner J, Lin B, Zhao W, Saul I, Busto R, Ginsberg MD.

Transient changes of brain-derived neurotrophic factor (BDNF) mRNA expression in hippocampus during moderate ischemia induced by chronic bilateral common carotid artery occlusions in the rat.

Brain Res Mol Brain Res 2001;92(1):157-66

Schwartz AY, Sehba FA, Bederson JB.

Decreased nitric oxide availability contributes to acute cerebral ischemia after subarachnoid hemorrhage.

Neurosurgery 2000;47(1):208-214

Seidl R, Cairns N, Singewald N, Kaehler ST, Lubec G.

Differences between GABA levels in Alzheimer's disease and Down syndrome with Alzheimer-like neuropathology.

Naun Schm Arch Pharm 2001;363(2):139-145

Seif el Nasr M, Fahim AT.

Antioxidant effect of N omega-nitro-L-arginine methyl ester (L-NAME) on global cerebral ischemia in a rat model.

Arzneimittelforschung 2001;51(8):628-632

Sela M, Arnon R, Schechter B.

Theurapeutic vaccines: realities of today and hopes for the future. Drug Discovery Today 2002;7(12):664-673

Semenza GL, Agani F, Feldser D, Iyer N, Kotch L, Laughner E, Yu A.Hypoxia, HIF-1, and the pathophysiology of common human diseases. Adv Exp Med Biol 2000;475:123-130

Shcherbatykh TV, Kiryanov SA, Korovaitseva GI, Selezneva ND, Voskresenskaya NI, Golimbet VE, Farrer L, Gavrilova SI, Rogaev EI.

The angiotensin-converting enzyme gene as a possible risk or protective factor in Alzheimer's disease. Neurosci Behav Physiol 2001;31(2):179-181

Sheng JG, Jones RA, Zhou XQ, McGinness JM, Van Eldik LJ, Mrak RE, Griffin WS.Interleukin-1 promotion of MAPK-p38 overexpression in experimental animals and in Alzheimer's disease: potential significance for tau protein phosphorylation.

Neurochem Int 2001;39(5-6):341-348

Shi J, Bui JD, Yang SH, He Z, Lucas TH, Buckley DL, Blackband SJ, King MA, et al.

Estrogens decrease reperfusion-associated cortical ischemic damage: an MRI analysis in a transient focal ischemia model.

Stroke 2001;32(4):987-992

Shim KS, Lubec G.

Drebrin, a dendritic spine protein, is manifold decreased in brains of patients with Alzheimer's disease and Down syndrome.

Neurosci Lett 2002;324(3):209-212

Shin CM, Chung YH, Kim MJ, Cha CI.

Spatial and temporal distribution of pituitary adenylate cyclase activating polypeptide in gerbil global cerebral ischemia.

Neurosci Lett 2001;309(1):53-56

Shiozaki K, Iseki E, Hino H, Kosaka K.

Distribution of m1 muscarinic acetylcholine receptors in the hippocampus of patients with Alzheimer's disease and dementia with Lewy bodies-an immu-nohistochemical study.

J Neurol Sci 2001;193(1):23-28

Short RA, Bowen RL, O'Brien PC, Graff-Radford NR.Elevated gonadotropin levels in patients with Alzheimer disease. Mayo Clin Proc 2001;76(9):906-909

Simic G, Lucassen PJ, Krsnik Z, Kruslin B, Kostovic I, Winblad B, Bogdanovi.

nNOS expression in reactive astrocytes correlates with increased cell death related DNA damage in the hippocampus and entorhinal cortex in Alzheimer's disease.

Exp Neurol 2000;165(1):12-26

Singleton AB, Gibson AM, McKeith IG, Ballard CG, Edwardson JA, Morris CM.

Nitric oxide synthase gene polymorphisms in Alzheimer's disease and dementia with Lewy bodies. Neurosci Lett 2001;303(1):33-36

Siren AL, Ehrenreich H.

Erythropoietin-a novel concept for neuroprotection. Eur Arch Psych Clin Neurosci 2001; 251(4):179-184

Siren AL, Knerlich F, Poser W, Gleiter CH, Bruck W, Ehrenreich H.Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain. Acta Neuropathol (Berl) 2001;101(3):271-276

Skvortsova VI, Raevskii KS, Kovalenko AV, Kudrin VS, Malikova LA, Sokolov MA, Alekseev AA, Gusev EI.

Levels of neurotransmitter amino acids in the cerebrospinal fluid of patients with acute ischemic insult. Neurosci Behav Physiol 2000;30(5):491-495

Solerte SB, Ceresini G, Ferrari E, Fioravanti M.

Hemorheological changes and overproduction of cytokines from immune cells in mild to moderate dementia of the Alzheimer's type: adverse effects on cerebro-microvascular system.

Neurobiol Aging 2000;21(2):271-281

Steiner RA, Hohmann JG, Holmes A, Wrenn CC, Cadd G, Jureus A, et al.

Galanin transgenic mice display cognitive and neurochemical deficits characteristic of Alzheimer's disease.

PNAS USA 2001;98(7):4184-4189

Stepanichev MY, Onufriev MV, Mitrokhina OS, et al.

Neurochemical, behavioral, and neuromorphological effects of cerebral administration of ß-amyloid peptide (25-35) in rat.

Нейрохимия 2000;17(4):278-293

Не нашли, что искали? Воспользуйтесь поиском по сайту: